Coronary artery disease clinical trials

Explore recruiting coronary artery disease clinical trials.

Recruiting coronary artery disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Coronary artery disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to see how RO7763505 works and how safe it is when given to healthy people and people with stable heart disease

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

COLchicine in BElgium in patients with coronary artery disease after Percutaneous Coronary Intervention

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Specifying the anti-inflammatory effects of ziltivekimab with diverse imaging modalities and in-depth cellular phenotyping (SPIDER)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE)

Finland, France, Spain

Therapeutic use (Phase IV) EU CTIS Study details

Colchicine for ischemia with no obstructive coronary artery disease and microvascular dysfunction

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Coronary artery disease trials by city

Coronary artery disease in Toronto Coronary artery disease in Vancouver Coronary artery disease in Montreal Coronary artery disease in Calgary Coronary artery disease in Edmonton Coronary artery disease in Ottawa Coronary artery disease in Winnipeg Coronary artery disease in Quebec City Coronary artery disease in Hamilton Coronary artery disease in Kitchener Coronary artery disease in London Coronary artery disease in Halifax Coronary artery disease in New York Coronary artery disease in Los Angeles Coronary artery disease in Chicago Coronary artery disease in Houston

Other conditions

Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease IgA nephropathy Polycystic kidney disease Migraine Alzheimer's disease